Ligand validation:3OT9

G16: 1,6-di-O-phosphono-alpha-D-glucopyranose

G16 is a Ligand Of Interest in 3OT9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3OT9_G16_A_400	69%	38%	0.111	0.926	1.26	1.16	2	2	0	0	100%	0.75
3UN3_G16_A_399	42%	39%	0.154	0.874	1.22	1.18	1	3	1	0	100%	0.75
3UO0_G16_A_398	7%	43%	0.306	0.762	1.31	0.91	3	1	0	0	100%	0.5
5O9X_G16_A_601	97%	20%	0.074	0.987	1.76	1.64	4	4	0	0	100%	1
1O08_G16_A_501	88%	2%	0.092	0.969	4.96	2.16	5	6	0	1	100%	1
6NNT_G16_A_501	80%	44%	0.099	0.947	1.32	0.84	2	1	0	0	100%	0.83
7P5O_G16_A_601	59%	22%	0.175	0.959	1.44	1.76	2	9	2	0	100%	1
1O03_G16_A_501	56%	4%	0.114	0.883	3.98	1.71	4	6	1	1	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.